Biora Therapeutics Inc
NASDAQ:BIOR
Balance Sheet
Balance Sheet Decomposition
Biora Therapeutics Inc
Biora Therapeutics Inc
Balance Sheet
Biora Therapeutics Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
49
|
33
|
92
|
88
|
31
|
15
|
|
| Cash Equivalents |
49
|
33
|
92
|
88
|
31
|
15
|
|
| Short-Term Investments |
20
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
8
|
23
|
7
|
1
|
1
|
1
|
|
| Accounts Receivables |
2
|
22
|
7
|
1
|
0
|
0
|
|
| Other Receivables |
6
|
1
|
0
|
0
|
1
|
0
|
|
| Inventory |
8
|
11
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
4
|
8
|
28
|
10
|
7
|
3
|
|
| Total Current Assets |
89
|
75
|
126
|
99
|
38
|
19
|
|
| PP&E Net |
15
|
16
|
8
|
4
|
3
|
3
|
|
| PP&E Gross |
15
|
16
|
8
|
4
|
3
|
3
|
|
| Accumulated Depreciation |
14
|
17
|
6
|
6
|
4
|
2
|
|
| Intangible Assets |
6
|
5
|
0
|
0
|
0
|
0
|
|
| Goodwill |
6
|
6
|
6
|
6
|
6
|
6
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
6
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
14
|
0
|
0
|
0
|
|
| Other Assets |
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Assets |
116
N/A
|
102
-13%
|
154
+52%
|
109
-30%
|
54
-51%
|
31
-42%
|
|
| Liabilities | |||||||
| Accounts Payable |
11
|
16
|
17
|
9
|
4
|
3
|
|
| Accrued Liabilities |
61
|
78
|
50
|
31
|
14
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
5
|
6
|
5
|
22
|
6
|
44
|
|
| Total Current Liabilities |
78
|
100
|
73
|
62
|
23
|
63
|
|
| Long-Term Debt |
72
|
72
|
160
|
126
|
128
|
44
|
|
| Other Liabilities |
4
|
13
|
29
|
6
|
5
|
26
|
|
| Total Liabilities |
153
N/A
|
186
+21%
|
261
+41%
|
194
-26%
|
156
-20%
|
133
-15%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
143
|
349
|
541
|
789
|
827
|
951
|
|
| Additional Paid In Capital |
124
|
283
|
453
|
723
|
744
|
869
|
|
| Treasury Stock |
19
|
19
|
19
|
19
|
19
|
19
|
|
| Total Equity |
37
N/A
|
84
-127%
|
107
-28%
|
85
+21%
|
102
-20%
|
101
+1%
|
|
| Total Liabilities & Equity |
116
N/A
|
102
-13%
|
154
+52%
|
109
-30%
|
54
-51%
|
31
-42%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
2
|
2
|
2
|
7
|
9
|
3
|
|